National Healthcare Properties, Inc. (NHP)
Every figure below is the company's own, as filed. Nothing is estimated and
nothing is smoothed — a period the filing does not support is left blank rather than
drawn.
Quarters are the company's own, counted from its financial
year ending 12-31.
Amounts in USD.
Every figure as a table ›
Revenue Quarterly
0
35M
70M
105M
Q3 '21: 82M
Q4 '21: 82.8M
Q1 '22: 83.7M
Q2 '22: 83.8M
Q3 '22: 83.5M
Q4 '22: 84.9M
Q1 '23: 87.4M
Q2 '23: 86.1M
Q3 '23: 85.7M
Q4 '23: 86.8M
Q1 '24: 88.3M
Q2 '24: 88.8M
Q3 '24: 88.9M
Q4 '24: 87.7M
Q1 '25: 86.4M
Q2 '25: 85.3M
Q3 '25: 86M
Q4 '25: 84.5M
Q1 '26: 86.3M
Q2 '26: 87.5M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Gross Profit Quarterly
0
15M
30M
45M
Q3 '21: 30.8M
Q4 '21: 29.1M
Q1 '22: 30.6M
Q2 '22: 31.2M
Q3 '22: 32.3M
Q4 '22: 28.3M
Q1 '23: 33.5M
Q2 '23: 32.5M
Q3 '23: 31.4M
Q4 '23: 30.8M
Q1 '24: 33.2M
Q2 '24: 33.8M
Q3 '24: 32.5M
Q4 '24: 32.8M
Q1 '25: 28.6M
Q2 '25: 31.2M
Q3 '25: 32.2M
Q4 '25: 31.5M
Q1 '26: 33.4M
Q2 '26: 33.4M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Income Quarterly
-105M
-70M
-35M
0
35M
70M
105M
Q3 '21: -28.6M
Q4 '21: -7.6M
Q1 '22: -12.6M
Q2 '22: -5.9M
Q3 '22: -8.3M
Q4 '22: -4.7M
Q1 '23: 1.9M
Q2 '23: 813K
Q3 '23: -912K
Q4 '23: -6.6M
Q1 '24: -1.1M
Q2 '24: -100.4M
Q3 '24: -20.9M
Q4 '24: -1.1M
Q1 '25: 13M
Q2 '25: -5.5M
Q3 '25: 2.4M
Q4 '25: -6.6M
Q1 '26: 10.1M
Q2 '26: 5.1M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Net Income Quarterly
-120M
-80M
-40M
0
40M
80M
120M
Q3 '21: -40.5M
Q4 '21: -19.4M
Q1 '22: -23.4M
Q2 '22: -17.6M
Q3 '22: -19.9M
Q4 '22: -18.7M
Q1 '23: -14.1M
Q2 '23: -17.3M
Q3 '23: -16.1M
Q4 '23: -24.9M
Q1 '24: -15.6M
Q2 '24: -116.9M
Q3 '24: -40.8M
Q4 '24: -17M
Q1 '25: -1.5M
Q2 '25: -20.8M
Q3 '25: -12.5M
Q4 '25: -22.8M
Q1 '26: -4.3M
Q2 '26: -5.4M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating Cash Flow Quarterly
-105M
-70M
-35M
0
35M
70M
105M
Q3 '21: 8.4M
Q4 '21: 12.9M
Q1 '22: 5.9M
Q2 '22: 7.9M
Q3 '22: 7.4M
Q4 '22: 7.2M
Q1 '23: 5M
Q2 '23: 5.7M
Q3 '23: 5.7M
Q4 '23: 5.3M
Q1 '24: 2.5M
Q2 '24: 6.4M
Q3 '24: -95.2M
Q4 '24: 6.5M
Q1 '25: -21.2M
Q2 '25: 8.1M
Q3 '25: 10.2M
Q4 '25: 10M
Q1 '26: 9M
Q2 '26: 21.6M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Free Cash Flow Quarterly
-105M
-70M
-35M
0
35M
70M
105M
Q3 '21: 4.1M
Q4 '21: 5.3M
Q1 '22: 2.6M
Q2 '22: 2.1M
Q3 '22: -274K
Q4 '22: -4.1M
Q1 '23: 1.4M
Q2 '23: 182K
Q3 '23: 823K
Q4 '23: -3.1M
Q1 '24: -2.6M
Q2 '24: 393K
Q3 '24: -100.5M
Q4 '24: 946K
Q1 '25: -26.9M
Q2 '25: 1.4M
Q3 '25: 5.6M
Q4 '25: -1.8M
Q1 '26: 3.7M
Q2 '26: 16.3M
Q4 '21
Q3 '22
Q2 '23
Q1 '24
Q4 '24
Q3 '25
Q2 '26
Operating cash flow minus capital expenditure.
Shares Outstanding Quarterly
0
40M
80M
120M
Q4 '14: 83.4M
Q2 '20: 97.3M
Q3 '20: 99M
Q1 '21: 101.9M
Q2 '21: 103.4M
Q3 '21: 104.9M
Q1 '22: 108M
Q2 '22: 109.7M
Q3 '22: 111.4M
Q1 '23: 113.1M
Q2 '23: 113.1M
Q3 '23: 28.3M
Q1 '24: 28.3M
Q2 '24: 28.3M
Q3 '24: 28.3M
Q1 '25: 28.3M
Q2 '25: 28.3M
Q3 '25: 28.3M
Q1 '26: 28.3M
Q2 '26: 61.6M
Q2 '20
Q2 '21
Q2 '22
Q2 '23
Q2 '24
Q2 '25
Q2 '26
Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.
EPS TTM
-9.00
-6.00
-3.00
0.00
3.00
6.00
9.00
Q3 '20: -1.11
Q4 '20: -0.75
Q1 '21: -0.61
Q2 '21: -0.53
Q3 '21: -0.82
Q4 '21: -0.82
Q1 '22: -0.95
Q2 '22: -0.99
Q3 '22: -0.80
Q4 '22: -3.31
Q1 '23: -3.21
Q2 '23: -3.20
Q3 '23: -3.68
Q4 '23: -2.01
Q1 '24: -2.53
Q2 '24: -6.59
Q3 '24: -7.46
Q4 '24: -7.19
Q1 '26: -2.60
Q2 '26: -1.88
Q4 '20
Q3 '21
Q2 '22
Q1 '23
Q4 '23
Q3 '24
Q2 '26
The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.
Not drawn for NHP:
Cost of Revenue . Nothing in this filer's XBRL supports
it for the periods asked for. That is a gap in
the filing, not a zero, and drawing a flat line would be an invention.